Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-20

Clinical Trial Update: REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)

View source ↗

Summary

Clinical trial update indicates that a REKOVELLE PEN study for subcutaneous controlled ovarian stimulation in assisted reproductive technologies is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REKOVELLE PEN (follitropin delta)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility | Status: RECRUITING